StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP – Free Report) in a report published on Wednesday. The firm issued a hold rating on the stock.
Retractable Technologies Price Performance
Retractable Technologies stock opened at $0.62 on Wednesday. Retractable Technologies has a fifty-two week low of $0.56 and a fifty-two week high of $1.34. The stock has a market cap of $18.49 million, a PE ratio of -1.14 and a beta of 2.06. The firm’s 50-day simple moving average is $0.72 and its 200 day simple moving average is $0.93. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57.
Insider Buying and Selling at Retractable Technologies
In related news, CEO Thomas J. Shaw bought 71,422 shares of the company’s stock in a transaction on Friday, September 20th. The shares were purchased at an average cost of $0.82 per share, for a total transaction of $58,566.04. Following the completion of the purchase, the chief executive officer now directly owns 14,743,907 shares in the company, valued at $12,090,003.74. The trade was a 0.49 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Insiders have purchased a total of 179,515 shares of company stock worth $143,037 over the last three months. 55.00% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Recommended Stories
- Five stocks we like better than Retractable Technologies
- Buy P&G Now, Before It Sets A New All-Time High
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 Warren Buffett Stocks to Buy Now
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.